Genomics Market
Genomics Market Forecasts to 2030 - Global Analysis By Product (Consumables & Reagents, Instruments/Systems/Software and Other Products), Service, Study Type, Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Genomics Market is accounted for $46.2 billion in 2023 and is expected to reach $118.4 billion by 2030 growing at a CAGR of 14.4% during the forecast period. The study of an organism's whole genome, or collection of genes, is at the center of the scientific discipline known as genomics. All genes, their roles, interactions, and the structure and arrangement of the DNA within an organism are analyzed and characterized. It also has many applications in fields including medicine, agriculture, evolutionary biology, and more. Techniques like DNA sequencing and bioinformatics are frequently used in genomic research to collect and interpret genetic data.
According to the National Cancer Institute, by 2040, the number of new cancer cases is expected to rise by 29.5 million, while cancer-related fatalities will rise by 16.4 million.
Market Dynamics:
Driver:
Genomics in specialty medicine
Numerous pharmaceutical firms are making growing investments in the study of tailored medicine. With the use of personalized medicine, doctors can pinpoint a patient's precise needs and then prescribe medications and therapies in response. Better healthcare results are ensured by this strategy. Numerous possibilities for market participants will arise as a result of the growth of the customized medicine business.
Restraint:
Delicate instrument handling
Gene editing, amplification, sequencing, and multiplexing are just a few of the complicated and delicate techniques used in genomic investigations. These techniques include the use of sophisticated tools, including sequencers, centrifuges, analyzers, liquid handling equipment, and PCR and microarray equipment. Therefore, extreme caution must be used when using all of the devices. Handling such delicate devices is a significant market growth inhibitor.
Opportunity:
Increasing cancer rates
The prevalence of cancer and the growing use of next-generation sequencing in cancer research are important drivers of the market's expansion. The way cancer is identified and treated is changing as a result of genomics. The methods for detecting cancer from a blood sample are getting better because to genome research. Genomic research has led to a rise in hereditary cancer screening tests. As a result, the market is expanding due to the rising incidence of cancer and the effective use of genomics in cancer diagnosis and treatment.
Threat:
Cost and affordability
Despite improvements in DNA sequencing technology, whole genome sequencing and comprehensive genomic profiling are among the most costly genomic tests and analyses. The broad use of genomics in clinical practice is constrained by the high costs involved with genetic testing and interpretation, particularly in locations with limited resources or for people with poor financial means. The availability and accessibility of genomic goods and services are also impacted by financial a factor, which restrains the expansion of the industry.
Covid-19 Impact:
The early stage of the pandemic saw a little negative rise in the COVID-19 effect. This was caused by a decline in personalized medicine, cancer research, and other research efforts. The epidemic also caused difficulties in delivering post-sales services and the temporary closure of some academic institutions, which disrupted the market as a whole. To examine viral genetic material, laboratories employed the polymerase chain reaction (PCR) and next-generation sequencing (NGS).
The pathway analysis segment is expected to be the largest during the forecast period
The pathway analysis segment is expected to be the largest during the forecast period. One of the most rapidly expanding uses of route analysis is the creation of next-generation therapies. Since the advent of clinical genomics and tailored treatments, pathway-based analysis has drawn increased interest. This is mostly due to the assistance provided by genetics and individualized medicines for the in-depth investigation of the capacity to navigate illness networks and signaling pathways.
The research institutes segment is expected to have the highest CAGR during the forecast period
The research institutes segment is expected to have the highest CAGR during the forecast period. Researchers with a focus on genomics, financing from public and private foundations, and business partnerships are some of the reasons that contribute to the segment's dominance in the market for genomics services. Additionally, the research institutes category is anticipated to grow faster throughout the projection period due to collaborations with other academic institutions, hospitals, and biotechnology firms.
Region with largest share:
North America is projected to hold the largest market share during the forecast period due to the support of research institutes and pharmaceutical giants. Due to the effects of genetic expression on human health, genomics is now a crucial component of all illness research and therapeutic development. Additionally, the presence of cutting-edge healthcare infrastructure, which supports the expansion of technical advancements in this industry, and rising demand for biotechnology services in the area are anticipated to support regional growth.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period due to increased demand for genomics applications in diagnostics and the growing demand for novel therapeutic drugs to fight the increased incidence of diseases. Additionally, the rising incidence of chronic illnesses like cancer, greater government funding for research, and growing consumer awareness all contribute to the expansion of regional markets.
Key players in the market
Some of the key players in Genomics market include BGI Genomics, Myriad Genetics, Inc., Agilent Technologies, Quest Diagnostics Incorporated, Thermo Fisher Scientific, Inc., Eurofins Scientific, Danaher Corporation, Eppendorf AG, Bio-Rad Laboratories, Inc., Color Genomics, Inc., Agilent Technologies, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., Oxford Nanopore Technologies, Quest Diagnostics Incorporated, Pacific Biosciences of California, Inc. and Color Health, Inc.
Key Developments:
In June 2023, BGI Genomics was recognized as the GB/T 35770-2022/ISO 37301 Compliance Management System accreditation-approved company, after the extensive evaluation of BSI, a global testing, standardization, and certification authority.
In June 2023, Myriad Genetics and The University of Texas MD Anderson Cancer Center announced their collaboration aimed at metastatic renal cell carcinoma treatment selection and response research and incorporating Myriad’s minimal residual disease testing platform based on whole genome sequencing.
In April 2023, Bio-Rad Laboratories, Inc. pivoted their measurable residual disease (MRD) genomics research via a half dozen collaborations with companies and institutions to launch their new QX600™ Droplet Digital™ PCR System.
Products Covered:
• Consumables & Reagents
• Instruments/Systems/Software
• Other Products
Services Covered:
• Core Genomics Services
• Computational Services
• NGS-based Services
• Biomarker Translation Services
• Other Services
Technologies Covered:
• Epigenomics
• Biomarker Discovery
• Pathway Analysis
• Functional Genomics
• Other Technologies
Applications Covered:
• Agriculture and Animal research
• Drug Discovery and Development
• Other Applications
End Users Covered:
• Pharmaceutical & Biotechnology Companies
• Hospitals
• Diagnostics Centers
• Academic Institutes
• Clinical Research
• Healthcare Facilities
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.7 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Genomics Market, By Product
5.1 Introduction
5.2 Consumables & Reagents
5.3 Instruments/Systems/Software
5.4 Other Products
6 Global Genomics Market, By Service
6.1 Introduction
6.2 Core Genomics Services
6.3 Computational Services
6.4 NGS-based Services
6.5 Biomarker Translation Services
6.6 Other Services
7 Global Genomics Market, By Technology
7.1 Introduction
7.2 Epigenomics
7.2.1 Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
7.2.2 Chromatin Accessibility Assays
7.2.3 High-Resolution Melt (HRM)
7.2.4 Bisulfite Sequencing
7.2.5 Methylated DNA Immunoprecipitation (MeDIP)
7.2.6 Microarray Analysis
7.3 Biomarker Discovery
7.3.1 Real-time PCR
7.3.2 Mass Spectrometry
7.3.3 Microarray Analysis
7.3.4 Statistical Analysis
7.3.5 DNA Sequencing
7.3.6 Bioinformatics
7.4 Pathway Analysis
7.4.1 Microarray Analysis
7.4.2 Proteomics Tools
7.4.3 Real-time PCR
7.4.4 Bead-Based Analysis
7.5 Functional Genomics
7.5.1 Real-Time PCR
7.5.2 Mutational Analysis
7.5.3 RNA Interference
7.5.4 SNP Analysis
7.5.5 Transfection
7.5.6 Microarray Analysis
7.6 Other Technologies
8 Global Genomics Market, By Application
8.1 Introduction
8.2 Agriculture and Animal research
8.3 Drug Discovery and Development
8.4 Other Applications
8.4.1 Biofuel Research
8.4.2 Marine Research
8.4.3 Food Industry
8.4.4 Forensics
9 Global Genomics Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology companies
9.4 Hospitals
9.5 Diagnostics Centers
9.6 Academic Institutes
9.8 Clinical Research
9.9 Healthcare Facilities
9.9 Other End Users
10 Global Genomics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 BGI Genomics
12.2 Myriad Genetics, Inc.
12.3 Agilent Technologies
12.4 Quest Diagnostics Incorporated
12.5 Thermo Fisher Scientific, Inc.
12.6 Eurofins Scientific
12.7 Danaher Corporation
12.7 Eppendorf AG
12.9 Bio-Rad Laboratories, Inc.
12.10 Color Genomics, Inc.
12.11 Agilent Technologies
12.12 F. Hoffmann-La Roche Ltd.
12.12 GE Healthcare
12.14 Illumina, Inc.
12.15 Oxford Nanopore Technologies
12.16 Quest Diagnostics Incorporated
12.17 Pacific Biosciences of California, Inc.
12.17 Color Health, Inc.
List of Tables
1 Global Genomics Market Outlook, By Region (2021-2030) ($MN)
2 Global Genomics Market Outlook, By Product (2021-2030) ($MN)
3 Global Genomics Market Outlook, By Consumables & Reagents (2021-2030) ($MN)
4 Global Genomics Market Outlook, By Instruments/Systems/Software (2021-2030) ($MN)
5 Global Genomics Market Outlook, By Other Products (2021-2030) ($MN)
6 Global Genomics Market Outlook, By Service (2021-2030) ($MN)
7 Global Genomics Market Outlook, By Core Genomics Services (2021-2030) ($MN)
8 Global Genomics Market Outlook, By Computational Services (2021-2030) ($MN)
9 Global Genomics Market Outlook, By NGS-based Services (2021-2030) ($MN)
10 Global Genomics Market Outlook, By Biomarker Translation Services (2021-2030) ($MN)
11 Global Genomics Market Outlook, By Other Services (2021-2030) ($MN)
12 Global Genomics Market Outlook, By Technology (2021-2030) ($MN)
13 Global Genomics Market Outlook, By Epigenomics (2021-2030) ($MN)
14 Global Genomics Market Outlook, By Chromatin Immunoprecipitation (ChIP & ChIP-Seq) (2021-2030) ($MN)
15 Global Genomics Market Outlook, By Chromatin Accessibility Assays (2021-2030) ($MN)
16 Global Genomics Market Outlook, By High-Resolution Melt (HRM) (2021-2030) ($MN)
17 Global Genomics Market Outlook, By Bisulfite Sequencing (2021-2030) ($MN)
18 Global Genomics Market Outlook, By Methylated DNA Immunoprecipitation (MeDIP) (2021-2030) ($MN)
19 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
20 Global Genomics Market Outlook, By Biomarker Discovery (2021-2030) ($MN)
21 Global Genomics Market Outlook, By Real-time PCR (2021-2030) ($MN)
22 Global Genomics Market Outlook, By Mass Spectrometry (2021-2030) ($MN)
23 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
24 Global Genomics Market Outlook, By Statistical Analysis (2021-2030) ($MN)
25 Global Genomics Market Outlook, By DNA Sequencing (2021-2030) ($MN)
26 Global Genomics Market Outlook, By Bioinformatics (2021-2030) ($MN)
27 Global Genomics Market Outlook, By Pathway Analysis (2021-2030) ($MN)
28 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
29 Global Genomics Market Outlook, By Proteomics Tools (2021-2030) ($MN)
30 Global Genomics Market Outlook, By Real-time PCR (2021-2030) ($MN)
31 Global Genomics Market Outlook, By Bead-Based Analysis (2021-2030) ($MN)
32 Global Genomics Market Outlook, By Functional Genomics (2021-2030) ($MN)
33 Global Genomics Market Outlook, By Real-Time PCR (2021-2030) ($MN)
34 Global Genomics Market Outlook, By Mutational Analysis (2021-2030) ($MN)
35 Global Genomics Market Outlook, By RNA Interference (2021-2030) ($MN)
36 Global Genomics Market Outlook, By SNP Analysis (2021-2030) ($MN)
37 Global Genomics Market Outlook, By Transfection (2021-2030) ($MN)
38 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
39 Global Genomics Market Outlook, By Other Technologies (2021-2030) ($MN)
40 Global Genomics Market Outlook, By Application (2021-2030) ($MN)
41 Global Genomics Market Outlook, By Agriculture and Animal research (2021-2030) ($MN)
42 Global Genomics Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
43 Global Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
44 Global Genomics Market Outlook, By Biofuel Research (2021-2030) ($MN)
45 Global Genomics Market Outlook, By Marine Research (2021-2030) ($MN)
46 Global Genomics Market Outlook, By Food Industry (2021-2030) ($MN)
47 Global Genomics Market Outlook, By Forensics (2021-2030) ($MN)
48 Global Genomics Market Outlook, By End User (2021-2030) ($MN)
49 Global Genomics Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
50 Global Genomics Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
51 Global Genomics Market Outlook, By Diagnostics Centers (2021-2030) ($MN)
52 Global Genomics Market Outlook, By Academic Institutes (2021-2030) ($MN)
53 Global Genomics Market Outlook, By Clinical Research (2021-2030) ($MN)
54 Global Genomics Market Outlook, By Healthcare Facilities (2021-2030) ($MN)
55 Global Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
